94 related articles for article (PubMed ID: 7164166)
1. Trypanosoma brucei rhodesiense infection in vervet monkeys. I. Parasitologic, hematologic, immunologic and histologic results.
Schmidt H; Sayer P
Tropenmed Parasitol; 1982 Dec; 33(4):249-54. PubMed ID: 7164166
[TBL] [Abstract][Full Text] [Related]
2. Trypanosoma brucei rhodesiense infection in vervet monkeys. II. Provocation of the encephalitic late phase by treatment of infected monkeys.
Schmidt H; Sayer P
Tropenmed Parasitol; 1982 Dec; 33(4):255-9. PubMed ID: 7164167
[TBL] [Abstract][Full Text] [Related]
3. Influence of trypanocidal therapy on the haematology of vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense.
Ngotho M; Kagira JM; Kariuki C; Maina N; Thuita JK; Mwangangi DM; Farah IO; Hau J
Acta Trop; 2011 Jul; 119(1):14-8. PubMed ID: 21420376
[TBL] [Abstract][Full Text] [Related]
4. Immunospecific immunoglobulins and IL-10 as markers for Trypanosoma brucei rhodesiense late stage disease in experimentally infected vervet monkeys.
Ngotho M; Kagira JM; Jensen HE; Karanja SM; Farah IO; Hau J
Trop Med Int Health; 2009 Jul; 14(7):736-47. PubMed ID: 19573160
[TBL] [Abstract][Full Text] [Related]
5. Use of procyclic trypanosomes for detection of antibodies in sera from vervet monkeys infected with Trypanosoma rhodesiense: an immunodiagnostic test for African sleeping sickness.
Pearson TW; Liu M; Gardiner IC; Longridge D; Beecroft RP; Sayer PD; Gould SS; Waitumbi JN; Njogu AR
Acta Trop; 1986 Dec; 43(4):391-9. PubMed ID: 2882666
[TBL] [Abstract][Full Text] [Related]
6. IL-10 is up regulated in early and transitional stages in vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense.
Ngotho M; Maina N; Kagira J; Royo F; Farah IO; Hau J
Parasitol Int; 2006 Dec; 55(4):243-8. PubMed ID: 16901747
[TBL] [Abstract][Full Text] [Related]
7. Meningoencephalitis in chronic Trypanosoma brucei rhodesiense infection of the white mouse.
Fink E; Schmidt H
Tropenmed Parasitol; 1979 Jun; 30(2):206-11. PubMed ID: 113916
[TBL] [Abstract][Full Text] [Related]
8. The vervet monkey (Chlorocebus aethiops) as an experimental model for Trypanosoma brucei gambiense human African trypanosomiasis: a clinical, biological and pathological study.
Ouwe-Missi-Oukem-Boyer O; Mezui-Me-Ndong J; Boda C; Lamine I; Labrousse F; Bisser S; Bouteille B
Trans R Soc Trop Med Hyg; 2006 May; 100(5):427-36. PubMed ID: 16325877
[TBL] [Abstract][Full Text] [Related]
9. Serodiagnosis of African sleeping sickness in vervet monkeys by detection of parasite antigens.
Liu MK; Pearson TW; Sayer PD; Gould SS; Waitumbi JN; Njogu AR
Acta Trop; 1988 Dec; 45(4):321-30. PubMed ID: 2907259
[TBL] [Abstract][Full Text] [Related]
10. Trypanosoma brucei brucei: a long-term model of human African trypanosomiasis in mice, meningo-encephalitis, astrocytosis, and neurological disorders.
Keita M; Bouteille B; Enanga B; Vallat JM; Dumas M
Exp Parasitol; 1997 Feb; 85(2):183-92. PubMed ID: 9030668
[TBL] [Abstract][Full Text] [Related]
11. IgM, lgG and IL-6 profiles in the Trypanosoma brucei brucei monkey model of human African trypanosomiasis.
Waema MW; Maina NW; Ngotho M; Karanja SM; Gachie BM; Maranga DN; Kagira JM
Acta Trop; 2017 Apr; 168():45-49. PubMed ID: 28099874
[TBL] [Abstract][Full Text] [Related]
12. Trypanosoma brucei rhodesiense: use of an antigen detection enzyme immunoassay for evaluation of response to chemotherapy in infected vervet monkeys (Cercopithecus aethiops).
Gichuki CW; Nantulya VM; Sayer PD
Trop Med Parasitol; 1994 Sep; 45(3):237-42. PubMed ID: 7899795
[TBL] [Abstract][Full Text] [Related]
13. Evidence of blood cerebrospinal fluid barrier permeability impairment in Trypanosoma rhodesiense infection in vervet monkeys.
Waitumbi JN; Sayer PD; Gould SS
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):502-5. PubMed ID: 3197248
[TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of trypanosomiasis of the CNS. Studies on parasitological and neurohistological findings in trypanosoma rhodesiense infected vervet monkeys.
Schmidt H
Virchows Arch A Pathol Anat Histopathol; 1983; 399(3):333-43. PubMed ID: 6407189
[TBL] [Abstract][Full Text] [Related]
15. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
Gehrig S; Efferth T
Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
[TBL] [Abstract][Full Text] [Related]
16. Relapsed parasitaemia following chemotherapy of chronic T. brucei infections in mice and its relation to cerebral trypanosomes.
Jennings FW; Gray GD
Contrib Microbiol Immunol; 1983; 7():147-54. PubMed ID: 6825436
[TBL] [Abstract][Full Text] [Related]
17. IgG and IgM--levels in serum and CSF of T. rhodesiense-infected vervet monkeys.
Fink E; Sayer P; Schmidt H
Contrib Microbiol Immunol; 1983; 7():183-9. PubMed ID: 6825439
[No Abstract] [Full Text] [Related]
18. A multiplex PCR that discriminates between Trypanosoma brucei brucei and zoonotic T. b. rhodesiense.
Picozzi K; Carrington M; Welburn SC
Exp Parasitol; 2008 Jan; 118(1):41-6. PubMed ID: 17643434
[TBL] [Abstract][Full Text] [Related]
19. [Human African trypanosomiasis, contributions of experimental models].
Bouteille B; Millet P; Enanga B; Mezui Me J; Keita M; Jauberteau MO; Georges A; Dumas M
Bull Soc Pathol Exot; 1998; 91(2):127-32. PubMed ID: 9642464
[TBL] [Abstract][Full Text] [Related]
20. [Human African trypanosomiasis].
Dumas M; Bouteille B
C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
